drugset / Trial / NCT02181959

Safety and Tolerability of Pharmaton Capsules in Healthy Volunteers

NCT02181959 ↗

Phase 2 Completed 138 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this trial was to evaluate the safety and tolerability of a galenic formulation of Pharmaton® capsules containing 2-Dimethylaminoethanol (DMAE) in healthy volunteers.

Timeline

Start
1998-12
Primary completion
1999-04
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject 2-Dimethylaminoethanol Unknown — —
Comparator PHARMATON Unknown — —

Indications

No indication recorded.